Quartz Eli Lilly's experimental diabetes drug helped patients lose 17% of their body weight
Retatrutide reduced body weight by up to 16.8% over 40 weeks in a Phase 3 trial — and unlike Ozempic or Mounjaro, it activates three hormonal pathways at once
Retatrutide reduced body weight by up to 16.8% over 40 weeks in a Phase 3 trial — and unlike Ozempic or Mounjaro, it activates three hormonal pathways at once